Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 99, Issue 4, 2002, Pages 1921-1925

  Kumar, Monica V ^a   Shimokawa, Teruhiko ^a   Nagy, Tim R ^b   Lane, M Daniel ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

AgRP; CART; DIO; NPY; POMC

Indexed keywords

ANTIOBESITY AGENT; C 75; FATTY ACID SYNTHASE; MESSENGER RNA; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

4-BUTYROLACTONE; ANIMALS; BODY WEIGHT; DOWN-REGULATION; ENZYME INHIBITORS; FATTY ACID SYNTHETASE COMPLEX; HYPOTHALAMUS; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; RIBONUCLEASES; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

ANIMALIA;

EID: 0037133185     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.042683699     Document Type: Article

References (13)